RTW Investments’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,327,403
| Closed | -$7.42M | – | 111 |
|
|
2022
Q2 | $7.42M | Hold |
2,327,403
| – | – | 0.19% | 69 |
|
|
2022
Q1 | $9.94M | Sell |
2,327,403
-500
| -0% | -$2.18K | 0.21% | 66 |
|
|
2021
Q4 | $10.8M | Hold |
2,327,903
| – | – | 0.16% | 78 |
|
|
2021
Q3 | $9.29M | Hold |
2,327,903
| – | – | 0.14% | 81 |
|
|
2021
Q2 | $9.96M | Hold |
2,327,903
| – | – | 0.15% | 73 |
|
|
2021
Q1 | $9.87M | Sell |
2,327,903
-69,475
| -3% | -$383K | 0.15% | 70 |
|
|
2020
Q4 | $9.3M | Buy |
2,397,378
+2,349
| +0.1% | +$10K | 0.16% | 71 |
|
|
2020
Q3 | $9.65M | Buy |
2,395,029
+20,077
| +0.8% | +$83.2K | 0.23% | 64 |
|
|
2020
Q2 | $10.1M | Buy |
2,374,952
+20,218
| +0.9% | +$123K | 0.28% | 54 |
|
|
2020
Q1 | $9.89M | Buy |
2,354,734
+66,743
| +3% | +$422K | 0.43% | 43 |
|
|
2019
Q4 | $8.99M | Buy |
2,287,991
+271,722
| +13% | +$1.6M | 0.34% | 51 |
|
|
2019
Q3 | $17.7M | Buy |
2,016,269
+4,929
| +0.2% | +$46.6K | 1.06% | 25 |
|
|
2019
Q2 | $18.6M | Buy |
2,011,340
+1,710,174
| +568% | +$12.9M | 0.99% | 27 |
|
|
2019
Q1 | $1.94M | Buy |
301,166
+33,130
| +12% | +$216K | 0.13% | 45 |
|
|
2018
Q4 | $2.53M | Sell |
268,036
-929,071
| -78% | -$14M | 0.23% | 42 |
|
|
2018
Q3 | $24.1M | Sell |
1,197,107
-148,774
| -11% | -$3.89M | 1.44% | 19 |
|
|
2018
Q2 | $39.3M | Buy |
1,345,881
+223,341
| +20% | +$6.89M | 2.83% | 9 |
|
|
2018
Q1 | $33.4M | Buy |
1,122,540
+59,370
| +6% | +$1.91M | 3.18% | 9 |
|
|
2017
Q4 | $34.2M | Buy |
1,063,170
+18,863
| +2% | +$616K | 5.71% | 7 |
|
|
2017
Q3 | $36.3M | Sell |
1,044,307
-63,072
| -6% | -$2.03M | 6.33% | 6 |
|
|
2017
Q2 | $33M | Buy |
1,107,379
+78,450
| +8% | +$2.25M | 6.95% | 5 |
|
|
2017
Q1 | $30.7M | Sell |
1,028,929
-57,108
| -5% | -$1.46M | 8.08% | 4 |
|
|
2016
Q4 | $19M | Sell |
1,086,037
-84,114
| -7% | -$1.61M | 7.17% | 5 |
|
|
2016
Q3 | $27.8M | Sell |
1,170,151
-5,995
| -0.5% | -$113K | 8.41% | 4 |
|
|
2016
Q2 | $18.8M | Buy |
1,176,146
+7,081
| +0.6% | +$127K | 6.43% | 5 |
|
|
2016
Q1 | $24.4M | Buy |
1,169,065
+84,649
| +8% | +$1.51M | 8.87% | 3 |
|
|
2015
Q4 | $29.3M | Buy |
1,084,416
+4,085
| +0.4% | +$111K | 9.53% | 2 |
|
|
2015
Q3 | $30M | Buy |
1,080,331
+796,631
| +281% | +$25.1M | 9.33% | 3 |
|
|
2015
Q2 | $6.95M | Sell |
283,700
-780,547
| -73% | -$16.1M | 2.02% | 15 |
|
|
2015
Q1 | $19.5M | Hold |
1,064,247
| – | – | 8.79% | 6 |
|
|
2014
Q4 | $19.6M | Buy |
+1,064,247
| New | +$12.6M | 7.26% | 6 |
|
RTW Investments's LJPC Position: Q3 2022 in Review
RTW Investments sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 2,327,403 shares — an estimated $7.42M sold.
RTW Investments first reported a position in LJPC in Q4 2014 and held it in 31 quarters. The position peaked at $39.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- RTW Investments reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- RTW Investments sold 2,327,403 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $7.42M.
- RTW Investments first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and held it in 31 quarters.
- RTW Investments's La Jolla Pharmaceutical Company position peaked at $39.3M in Q2 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.